Brief: SYNLAB And Microba Expand Strategic Agreement On Advanced Gut Microbiome Test MyBIOME

Synlab AG

27/10/2022 08:21

Oct 27 (Reuters) - SYNLAB AG  SYAB.DE :
    * SYNLAB AND MICROBA REINFORCE THEIR COMBINED EXPERTISE AND
EXPAND
STRATEGIC AGREEMENT ON ADVANCED GUT MICROBIOME TEST MYBIOME
    * LAUNCHED IN SPAIN AND COLOMBIA IN 2020, MYBIOME IS AN
INNOVATIVE
GUT MICROBIOME EXAMINATION BASED ON TECHNOLOGY DEVELOPED BY
MICROBA'S LEADING RESEARCHERS IN FIELD OF MICROBIOME ANALYSIS
    * SYNLAB AND MICROBA ARE NOW EXTENDING OFFERING TO WIDER
DISTRIBUTION ACROSS EUROPE AND LATIN AMERICA
    * COMBINATION OF LEADING-EDGE COMPREHENSIVE METAGENOMIC
SEQUENCING
AND EVIDENCE-BASED REPORTING PROVIDES PRECISE IMAGING OF GUT
MICROBIOME

Source text for Eikon:  ID:nEQ2SwMvya 
Further company coverage:  SYAB.DE 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))